Literature DB >> 23264312

Is opioid-induced hyperalgesia reversible? A study on active and former opioid addicts and drug naïve controls.

Roi Treister1, Elon Eisenberg, Eli Lawental, Dorit Pud.   

Abstract

OBJECTIVE: Hyperalgesia has been observed in active opioid addicts (OAs). The aim of this study was to explore whether opioid-induced hyperalgesia (OIH) is a reversible phenomenon.
DESIGN: Observational study. PARTICIPANTS: The study included the following three groups of male subjects: 1) active addicts on heroin or methadone (OAs, n = 50); 2) former opioid addicts with at least 5 months of abstinence from drug use (FOAs, n = 43); and 3) drug naïve controls (C, n = 50).
INTERVENTIONS: All subjects were exposed to the cold pressor test (1°C). MAIN OUTCOME MEASURES: Cold pain threshold (latency to pain onset, seconds) and cold pain tolerance (latency to pain intolerability, seconds).
RESULTS: Mean ± standard deviation (SD) pain thresholds were 10.8 ± 7.7, 6.9 ± 3.9, and 6.8 ± 3.5 seconds for the OAs, FOAs, and C groups, respectively (analysis of variance [ANOVA], p = 0.002, 95% CI = 7.5-9.2). Mean ± SD pain tolerance levels were 30 ± 36.2, 64 ± 58.1, and 56.4 ± 51.4 seconds for the OAs, FOAs, and C groups, respectively (ANOVA, p < 0.001, 95% CI = 43-60.4). Post hoc analyses revealed significant changes between the OAs and the other two groups for both variables.
CONCLUSIONS: It is suggested that altered pain perception in OAs is a reversible phenomenon that may require a long period of abstinence to reset, rather than being an individual long-term stable trait.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23264312     DOI: 10.5055/jom.2012.0134

Source DB:  PubMed          Journal:  J Opioid Manag        ISSN: 1551-7489


  7 in total

1.  Withdrawal-associated injury site pain prevalence and correlates among opioid-using people who inject drugs in Vancouver, Canada.

Authors:  Launette Marie Rieb; Kora DeBeck; Kanna Hayashi; Evan Wood; Ekaterina Nosova; M-J Milloy
Journal:  Drug Alcohol Depend       Date:  2020-08-18       Impact factor: 4.492

2.  Mechanisms, diagnosis, prevention and management of perioperative opioid-induced hyperalgesia.

Authors:  Sylvia H Wilson; Kevin M Hellman; Dominika James; Adam C Adler; Arvind Chandrakantan
Journal:  Pain Manag       Date:  2021-03-29

3.  Low Back Pain and Substance Use: Diagnostic and Administrative Coding for Opioid Use and Dependence Increased in U.S. Older Adults with Low Back Pain.

Authors:  Beth B Hogans; Bernadette C Siaton; Michelle N Taylor; Leslie I Katzel; John D Sorkin
Journal:  Pain Med       Date:  2021-04-20       Impact factor: 3.750

4.  Increased Experimental Pain Sensitivity in Chronic Pain Patients Who Developed Opioid Use Disorder.

Authors:  Peggy A Compton; Thomas E Wasser; Martin D Cheatle
Journal:  Clin J Pain       Date:  2020-09       Impact factor: 3.423

5.  Linking opioid-induced hyperalgesia and withdrawal-associated injury site pain: a case report.

Authors:  Launette Marie Rieb; Wendy V Norman; Ruth Elwood Martin; Jonathan Berkowitz; Evan Wood; Michael John Milloy; Ryan McNeil
Journal:  Pain Rep       Date:  2018-04-05

6.  Withdrawal-associated injury site pain (WISP): a descriptive case series of an opioid cessation phenomenon.

Authors:  Launette Marie Rieb; Wendy V Norman; Ruth Elwood Martin; Jonathan Berkowitz; Evan Wood; Ryan McNeil; M-J Milloy
Journal:  Pain       Date:  2016-12       Impact factor: 7.926

7.  Persistent adverse effects of antidepressants.

Authors:  Joanna Moncrieff
Journal:  Epidemiol Psychiatr Sci       Date:  2019-09-23       Impact factor: 6.892

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.